OCULAR MELANOMA
Clinical trials for OCULAR MELANOMA explained in plain language.
Never miss a new study
Get alerted when new OCULAR MELANOMA trials appear
Sign up with your email to follow new studies for OCULAR MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for brain metastases
Disease control CompletedThis early study tested whether combining an immunotherapy drug (pembrolizumab) with precise radiation (stereotactic radiosurgery) is safe for people with melanoma or lung cancer that has spread to the brain. 25 participants received the combination. The main goal was to check fo…
Matched conditions: OCULAR MELANOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 05:01 UTC
-
New immune cell attack shows promise for tough melanomas
Disease control CompletedThis early-phase study tested a new treatment called TBio-4101 for people with advanced melanoma that had stopped responding to standard therapies. The treatment uses a patient's own immune cells (TILs) that are selected and grown in the lab, then given back after chemotherapy to…
Matched conditions: OCULAR MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New drug shows promise in High-Risk eye cancer trial
Disease control CompletedThis study tested a drug called darovasertib in 15 people with a high-risk eye cancer called uveal melanoma. Participants took the drug for up to 4 weeks before eye removal surgery, and some continued for 6 months after. The main goal was to see if the drug is safe and tolerable,…
Matched conditions: OCULAR MELANOMA
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Scientists decode DNA of rare eye tumors to unlock cancer secrets
Knowledge-focused CompletedThis study looked at DNA changes (mutations) in eye cancers called ocular melanoma. Researchers analyzed tumor and blood samples from 58 patients to understand how these cancers develop and spread. The goal was to learn more about this rare cancer and find clues for future treatm…
Matched conditions: OCULAR MELANOMA
Sponsor: The Wellcome Sanger Institute • Aim: Knowledge-focused
Last updated May 26, 2026 05:07 UTC